The role of TIM-4 in efferocytosis is critical for normal immune modulation; however when patients undergo classical cancer therapies such as chemotherapy or radiation, the rapid clearance of dying tumor cells results in ineffective antigen presentation leading to a dampened immune response (reviewed in [20]). The gene discussed is TIMD4; the disease is cancer.